Business Wire

New Airline CO2 Emissions Monitor From Cirium Reveals 40% Less Fuel Burnt From Flights Flown Globally In 2021

10.11.2021 11:00:00 EET | Business Wire | Press release

Share

Cirium, the aviation analytics company, today launched its Global Aircraft Emissions Monitor, providing a highly accurate measure of CO2 emissions and fuel consumption from flights flown globally.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211110005600/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Cirium data shows the global flights tracked and fuel burn Jan-Nov 2021 versus 2019. (Graphic: Business Wire)

New insights from Cirium show that airlines have burnt 40% less fuel from flights in 2021 year-to-date compared to the same period in 2019.

The reduction in flight-produced carbon emissions is attributed to the drop in flights worldwide because of the dramatic impact that COVID-19 had on air travel. Flights tracked year-to-date are 29% down versus 2019.

The fuel burn has increased as domestic and international flights have started to return but not as much as expected compared to 2019—before the pandemic. The airlines have been flying their aircraft far fewer hours and prioritizing more efficient aircraft.

“To achieve the aggressive targets for aviation to reach net zero emissions by 2050, a thorough understanding is needed of all elements of an aircraft used for flights and the exact flight operations,” said Jeremy Bowen, CEO at Cirium.

“Cirium’s Global Aircraft Emissions Monitor boasts data of the highest quality and validity. The need for greater sustainability is clear and Cirium is committed to supporting the industry’s decision-making based on accurate carbon emissions tracking.”

The uniqueness of the product derives from the data, which is obtained from the widest and deepest data warehouse in the aviation industry. No other independent source can provide calculations based on the same blended data sets. The Monitor’s custom data calculations are based on hundreds of flight and aircraft variables for maximum accuracy. These variables include actual flight and taxi times, cabin configuration, aircraft operating empty weight, assumed cargo tonnage, aircraft/engine type, winglet equipage, aircraft age and more.

Tests conducted on the Global Aircraft Emissions Monitor have validated its accuracy in the order of 1%.

The Global Aircraft Emissions Monitor includes customized options for CO2 emissions and fuel consumption. It applies complete profiles of actual flights and aircraft, which are fused with block fuel burn models.

While aviation has reduced its emissions overall this year, travel is recovering, with Cirium forecasts projecting for global recovery to 2019 levels potentially by 2023. Cirium’s Fleet Forecast also predicts that based on the flight capacity of the increasing fleet to be in service by 2039, fuel burn may reach 485 million tons. This equates to 1,530 million tons of CO2 emissions, excluding any initiatives for sustainable aviation fuels (SAF) or offsetting.

Carbon emissions and fuel consumption from flights are increasingly becoming the centre focus for all airlines, airports aviation finance, aircraft manufacturers, air traffic management, government, and fuel providers.

The comprehensiveness of the Cirium Global Aircraft Emissions Monitor will enable organizations to track emissions as a measure of efficiency, understand aspects of total cost of ownership, understand the profile of a current operator, gain a better understanding of the climate impact, benchmark the competition, and create fuel demand models.

Find out more at https://cirium.com/EmissionsMonitor .

-End-

For further information please visit https://www.cirium.com and follow Cirium updates via LinkedIn and Twitter.

About Cirium

Cirium brings together powerful data and analytics to keep the world moving. Delivering insight, built from decades of experience in the sector, enabling travel companies, aircraft manufacturers, airports, airlines and financial institutions, among others, to make logical and informed decisions which shape the future of travel, growing revenues and enhancing customer experiences. Cirium is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For media enquiries please contact:
Mike Arnot, Juliett Alpha via cirium@juliettalpha.com
or the Cirium media team at media@cirium.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 23:30:00 EET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

Multi-Color Corporation Receives Court Approval of First Day Motions4.2.2026 22:30:00 EET | Press release

Multi-Color Corporation (“MCC” or the “Company”), a global leader in prime label solutions, today announced that it has received approval from the U.S. Bankruptcy Court for the District of New Jersey (the “Court”) for first day relief related to its prepackaged Chapter 11 filed on January 29, 2026. The approved relief affirms that the Company will operate in the normal course, pay all trade vendors and suppliers in full, and maintain a strong liquidity position during the restructuring. As part of this relief, the Court granted MCC immediate access to $125 million of $250 million in debtor-in-possession (“DIP”) new money financing, provided by certain holders of MCC’s secured first lien debt and its equity sponsor, CD&R. This funding will capitalize the business through the initial stages of the prepackaged Chapter 11 process. The Court also granted MCC authority to pay trade vendors and suppliers in full in the ordinary course, maintain wages and benefits without interruption, satisfy

InterSystems Honored with Four 2026 Best in KLAS Awards4.2.2026 19:00:00 EET | Press release

InterSystems, a creative data technology provider powering more than one billion health records globally, today announced it has received four Global 2026 Best in KLAS awards. The company earned a #1 ranking for Acute Care EHR in Asia, Oceania, and France, as well as for Shared Care Records in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204241673/en/ InterSystems earns four Best in KLAS awards for 2026 Best in KLAS is KLAS Research’s annual recognition of top-performing healthcare technology and services solutions, based entirely on feedback from healthcare provider organizations. Awards are given within defined software and services market segments evaluated by KLAS Research using a standardized methodology that reflects customer experience and performance. In addition to U.S. market segments, KLAS also recognizes top-performing solutions through its Global (Non-U.S.) Best in KLAS Awards, which are based on fe

Onego Bio Strengthens Board with Appointment of Dr. Antti Vasara4.2.2026 17:00:00 EET | Press release

Onego Bio, the food ingredient company producing non-animal egg protein through precision fermentation, today announced that Dr. Antti Vasara has joined its board of directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204881159/en/ Dr. Antti Vasara Dr. Vasara brings more than 25 years of global experience in science, technology, and commercial strategy. Most recently, he served as President and CEO of VTT Technical Research Centre of Finland, where he led one of Europe’s foremost deep tech research organizations. His distinguished career spans senior leadership roles in industry and innovation policy—including impactful work with Nokia and strategic contributions to European research and development initiatives. “Antti is one of the most respected leaders in science and innovation,” said Maija Itkonen, CEO of Onego Bio. “His deep understanding of technology commercialization and ecosystem level strategy will be inva

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye